Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Implantable Brain-Computer Interface Supports Stroke Recovery and Assistive Function

By HospiMedica International staff writers
Posted on 06 Apr 2026

Stroke leaves many survivors with chronic motor deficits that limit independence, and cognitive decline is a growing concern in aging populations. More...

Stroke is a leading cause of long-term disability in the United States, with about 690,000 new survivors each year. Clinicians need therapies that translate neural intent into practical function during recovery and beyond. A new intent‑driven brain‑computer interface system has launched to support post‑stroke rehabilitation and day‑to‑day assistive independence.

Epia Neuro has introduced a proprietary neural interface platform intended to restore independence for people living with neurological conditions. The lead product is designed as a dual‑phase stroke therapy that supports both post‑stroke recovery and long‑term assistive living. The company is advancing toward first‑in‑human system demonstrations this year at the Department of Neurosurgery at Lenox Hill Hospital in New York.

The platform combines a minimally invasive, long‑lifetime “read/write” brain‑computer interface (BCI) with assistive devices and AI-driven support. Its implantable interface is engineered for surgical scalability and durability and can be placed within the skull in under an hour without piercing the dura, creating a workflow aimed at broad neurosurgical adoption. The implanted system is externally invisible, recharged via a non‑invasive headset, and designed for long‑term use with the option to be replaced or upgraded.

For stroke survivors, the system is being trained to interpret user intent in real time. Neural signals are fused with contextual data from external sensors to predict and drive assistive actions, including control of an upper‑limb grip‑assist motor prosthetic designed to be accessible and simple to replace. Beyond sensing, the platform supports both cortical stimulation and deep brain stimulation where clinically appropriate.

Epia Neuro’s initial clinical focus is stroke‑related motor impairment, with planned expansion to cognitive decline and other neurological disorders. The company’s platform advances work originally developed by iota Biosciences and integrates implantable interfaces, adaptive algorithms, and assistive devices to translate neural intent into real‑world action.

“Epia Neuro was founded to restore meaningful function, provide real independence and ultimately provide the support individuals need to be fully present in their lives. Over the past five years, our team has been building our first product: a system that interprets neural intent in real time and translates it into rehabilitation therapies and practical, everyday assistance. We’re starting with stroke and plan to rapidly expand into additional neurological conditions,” said Michel Maharbiz, Ph.D., Chief Executive Officer at Epia Neuro.

“Restoring function after neurological injury requires not just decoding signals, but translating them into meaningful, real-world actions for individuals post stroke. What is compelling about Epia Neuro’s approach is its focus on real-time interpretation of neural intent and its potential to deliver practical, day-to-day independence, starting with a focus on people with stroke where the unmet need is enormous,” said David J. Lin, M.D., critical care neurologist, neurorehabilitation specialist, and Director of Massachusetts General Hospital's Neurorecovery Clinic.

Related Links
Epia Neuro


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Radiofrequency Generator
GX1
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.